Salvage therapies for radiation-relapsed isocitrate dehydrogenase-mutant astrocytoma and 1p/19q codeleted oligodendroglioma

BACKGROUND: Optimal management for recurrent IDH-mutant glioma after radiation therapy (RT) is not well-defined. This study assesses practice patterns for managing recurrent IDH-mutant astrocytoma (Astro) and 1p/19q codeleted oligodendroglioma (Oligo) after RT and surveys their clinical outcomes aft...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Sirui, Rudra, Soumon, Campian, Jian L, Chheda, Milan G, Johanns, Tanner M, Ansstas, George, Abraham, Christopher D, Chicoine, Michael R, Leuthardt, Eric C, Dowling, Joshua L, Dunn, Gavin P, Kim, Albert H, Huang, Jiayi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324173/
https://www.ncbi.nlm.nih.gov/pubmed/34345818
http://dx.doi.org/10.1093/noajnl/vdab081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324173/
https://www.ncbi.nlm.nih.gov/pubmed/34345818
http://dx.doi.org/10.1093/noajnl/vdab081

Ejemplares similares